Skip to content
1 min left
0% read
Evolv Technology logo

Evolv Technology

Technology Company
Waltham, Massachusetts, USA
Founded 2013
275

Our mission is to help make places safer for people to live, work, learn, and play.

Share:

Evolv Security Solutions

Evolv aims to help organizations detect potential threats, mitigate risk, and enhance safety using AI-powered security solutions with robust insights. A connected and layered approach that integrates people and technology to help deter, detect, and orchestrate response to physical security threats. Unlike standalone products, the Safer Experience System combines brandished firearm detection, concealed weapons detection, a personal safety app, and data analytics into a unified security infrastructure.

Frequently Asked Questions About Evolv Technology

Evolv Technology is a finance company. Our mission is to help make places safer for people to live, work, learn, and play.

Evolv aims to help organizations detect potential threats, mitigate risk, and enhance safety using AI-powered security solutions with robust insights. A connected and layered approach that integrates people and technology to help deter, detect, and orchestrate response to physical security threats.

Evolv Technology has been operating since 2013. You can verify their legitimacy through their official website and social media presence.

Evolv Technology operates in the finance sector of the cryptocurrency industry. Compare Evolv Technology with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Evolv Technology, research their track record (operating since 2013), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Evolv Technology is based in Waltham, Massachusetts, USA, has been operating since 2013. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Evolv Technology is based in Waltham, Massachusetts, USA, North America.

Evolv Technology was founded in 2013. The company currently has 275 employees.

Evolv Technology Details

Evolv Technology Tags

More About Evolv Technology

Work Model Details
Employees engage in a combination of remote and on-site work.

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m